Commitments and Contingencies - Other Agreements - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
May 31, 2026 |
|
| Commitments and Contingencies [Line Items] | |||||
| Research and development | $ 27,622 | $ 22,563 | $ 93,010 | $ 80,265 | |
| Lessee renewal term | 5 years | ||||
| Right of use asset obtained in operating lease liability | $ 10,000 | ||||
| Lessee, finance lease, term of contract (in years) | 3 years | 3 years | |||
| Amount of finance leases capitalized during the period | $ 1,200 | 1,600 | |||
| Fixed payments for leases that had not yet commenced | $ 1,400 | $ 1,400 | |||
| Unrecorded unconditional purchase obligation, term (in years) | 3 years | ||||
| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | |||||
| Commitments and Contingencies [Line Items] | |||||
| Research and development | $ 700 | 2,700 | |||
| Research and development, amounts reimbursable from the third party | $ 100 | $ 1,000 | |||
| X | ||||||||||
- Definition Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase in right-of-use asset obtained in exchange for finance lease liability. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase in right-of-use asset obtained in exchange for operating lease liability. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of unrecorded obligation to transfer funds in future for fixed or minimum amount or quantity of product and service at fixed or minimum price. Includes, but is not limited to, lease not yet commenced and take-or-pay and throughput contracts. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Commitments and contingencies. No definition available.
|
| X | ||||||||||
- Definition Research And Development Expense, Reimbursable Amount No definition available.
|
| X | ||||||||||
- Details
|